HMOX1靶向药基因索拉非尼  舒尼替尼

基因名称:HMOX1  (heme oxygenase 1)

别名: HMOX1D,HO-1,HSP32,bK286B10
基因ID:3162
Chromosome(GRCh37) :22 Start: 35776354 End: 35790207 Strand: 1
信号通路:
靶向药: 索拉非尼 
舒尼替尼
化疗药:

简介:血红素加氧酶是血红素分解代谢中的一种重要酶,它将血红素分解成胆绿素,胆绿素还原酶和一氧化碳(一种公认的神经递质)随后将胆绿素转化为胆红素。血红素加氧酶活性是由底物血红素和各种非血红素物质诱导的。血红素加氧酶以2种同工酶、一种诱导性血红素加氧酶-1和一种组成性血红素加氧酶-2的形式存在。hmox1和hmox2属于血红素加氧酶家族。Heme oxygenase, an essential enzyme in heme catabolism, cleaves heme to form biliverdin, which is subsequently converted to bilirubin by biliverdin reductase, and carbon monoxide, a putative neurotransmitter. Heme oxygenase activity is induced by its substrate heme and by various nonheme substances. Heme oxygenase occurs as 2 isozymes, an inducible heme oxygenase-1 and a constitutive heme oxygenase-2. HMOX1 and HMOX2 belong to the heme oxygenase family.
HMOX1突变与药物:
EXPRESSION
药物:
索拉非尼 
舒尼替尼 
疾病:
肾细胞癌

常见问题
  • 如何在体龙基因完成所需的检测项目 流程简述 :在线咨询 - 采样送检 - 付款检测 - 检测分析 - 报告结果
查看详情

相关内容

官方客服团队

为您解决烦忧 - 24小时在线 专业服务